Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Dudler

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Revue Medicale Suisse|January 16, 2026
[Rheumatology : what's new in 2025]Marie Dudler, Thomas Reygaerts, Jean Dudler
Swiss Medical Weekly|April 13, 2012
Steroids for LBP - from rationale to inconvenient truthFederico Balagué, Valérie Piguet, Jean Dudler
Clinical Rheumatology|December 20, 2013
Cranial neuropathies in granulomatosis with polyangiitis (Wegener's): a case-based reviewAna Söderström, Sylvie Revaz, Jean Dudler
Clinical Rheumatology|January 4, 2014
Fear of impending fractures: when to refer? A case-based reviewCaroline Kronisch, Federico Balagué, Jean Dudler
Revue Medicale Suisse|March 19, 2026
[Biological treatments for rheumatology : specific situations and risks]Antoine Folly, Farah Ahmanna Chakir, Jean Dudler
Revue Medicale Suisse|July 5, 2021
[Methotrexate use: untangling the real from the fake]Farah Ahmanna Chakir, Antoine Folly, Jean Dudler
Revue Medicale Suisse|May 2, 2025
[Biological treatments for rheumatology : demystifying the risks]Antoine Folly, Farah Ahmanna Chakir, Jean Dudler
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 18, 2011
Terminal phalangeal osteosclerosis and rheumatoid arthritisMichael Currat, Bérengère Aubry-Rozier, Jean Dudler
Revue Medicale Suisse|March 12, 2010
[Prevention of cortisone-induced osteoporosis: who, when and what?]Bérengère Aubry-Rozier, Olivier Lamy, Jean Dudler
Joint Bone Spine|July 10, 2012
Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registryPascal Zufferey, Jean Dudler, Almut Scherer, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Revue Medicale Suisse|January 16, 2026
[Rheumatology : what's new in 2025]Marie Dudler, Thomas Reygaerts, Jean Dudler
Swiss Medical Weekly|April 13, 2012
Steroids for LBP - from rationale to inconvenient truthFederico Balagué, Valérie Piguet, Jean Dudler
Clinical Rheumatology|December 20, 2013
Cranial neuropathies in granulomatosis with polyangiitis (Wegener's): a case-based reviewAna Söderström, Sylvie Revaz, Jean Dudler
Clinical Rheumatology|January 4, 2014
Fear of impending fractures: when to refer? A case-based reviewCaroline Kronisch, Federico Balagué, Jean Dudler
Revue Medicale Suisse|March 19, 2026
[Biological treatments for rheumatology : specific situations and risks]Antoine Folly, Farah Ahmanna Chakir, Jean Dudler
Revue Medicale Suisse|July 5, 2021
[Methotrexate use: untangling the real from the fake]Farah Ahmanna Chakir, Antoine Folly, Jean Dudler
Revue Medicale Suisse|May 2, 2025
[Biological treatments for rheumatology : demystifying the risks]Antoine Folly, Farah Ahmanna Chakir, Jean Dudler
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 18, 2011
Terminal phalangeal osteosclerosis and rheumatoid arthritisMichael Currat, Bérengère Aubry-Rozier, Jean Dudler
Revue Medicale Suisse|March 12, 2010
[Prevention of cortisone-induced osteoporosis: who, when and what?]Bérengère Aubry-Rozier, Olivier Lamy, Jean Dudler
Joint Bone Spine|July 10, 2012
Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registryPascal Zufferey, Jean Dudler, Almut Scherer, et al.
Pageof 8